Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study.

Authors :: Zager JS
Orloff M
Ferrucci PF
Choi J
Eschelman DJ
Glazer ES
Ejaz A
Howard JH
Richtig E
Ochsenreither S
Reddy SA
Lowe MC
Beasley GM
Gesierich A
Bender A
Gschnell M
Dummer R
Rivoire M
Arance A
Fenwick SW
Sacco JJ
Haferkamp S
Weishaupt C
John J
Wheater M
Ottensmeier CH
Source :: Annals of surgical oncology [Ann Surg Oncol] 2024 Nov; Vol. 31 (12), pp. 8262-8263.
Publication Year :: 2024

Full Text Access

Tools